These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8637471)

  • 1. The risks and benefits of antithrombotic therapy in chronic atrial fibrillation.
    Hankey GJ; Gray NJ
    Med J Aust; 1996 May; 164(10):624-6. PubMed ID: 8637471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Warfarin and aspirin as thromboprophylaxis in atrial fibrillation.
    Lip GY; Lowe GD
    Br J Clin Pharmacol; 1996 May; 41(5):369-79. PubMed ID: 8735677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin for atrial fibrillation.
    Douglas M; Strelnick A
    J Fam Pract; 2000 Jan; 49(1):7-8. PubMed ID: 10678329
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic atrial fibrillation: optimizing anticoagulation.
    Wheeldon NM
    QJM; 1997 Oct; 90(10):609-11. PubMed ID: 9415341
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: The Clinical Quality Improvement Network (CQIN) Investigators. Thromboembolic prophylaxis in 3,575 hospitalized patients with atrial fibrillation. 1998;14:695-702.
    Tsuyuki RT; Walters B; Yim R; Teo KK
    Can J Cardiol; 2000 Jan; 16(1):99. PubMed ID: 10702003
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
    Själander A; Wallentin L; Rosenqvist M; Svensson P
    Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-thrombotic therapy for non-rheumatic atrial fibrillation.
    More RS; Chauhan A
    QJM; 1996 Jun; 89(6):409-14. PubMed ID: 8758043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why is warfarin underutilized in patients with atrial fibrillation?
    Flaker GC; Schutz J
    J Interv Card Electrophysiol; 2004; 10 Suppl 1():21-5. PubMed ID: 14739736
    [No Abstract]   [Full Text] [Related]  

  • 9. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S; Trappolini M; Chillotti FM
    Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clopidogrel-aspirin combination for atrial fibrillation: CLAAF is not CLEAR.
    Jackson SL; Peterson GM; Bereznicki LR
    Am Heart J; 2005 Jan; 149(1):e3; author reply e4. PubMed ID: 15660026
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence-based emergency medicine. Anticoagulation or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.
    Diner BM
    Ann Emerg Med; 2003 Jan; 41(1):141-3. PubMed ID: 12514695
    [No Abstract]   [Full Text] [Related]  

  • 12. Evolving strategies to prevent stroke and thromboembolism in nonvalvular atrial fibrillation.
    Hussein A; Saliba W; Wazni OM
    Cleve Clin J Med; 2015 Dec; 82(12 Suppl 2):S11-6. PubMed ID: 26694887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
    Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China.
    Hu D; Sun Y
    J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352
    [No Abstract]   [Full Text] [Related]  

  • 15. [Guidelines for antithrombotic therapy in atrial fibrillation: what the Italian Hemostasis and Thrombosis Society thinks].
    Prisco D
    Haematologica; 2001 Sep; 86(9 Suppl):12-3. PubMed ID: 11759618
    [No Abstract]   [Full Text] [Related]  

  • 16. Current status of anticoagulation therapy for elderly atrial fibrillation patients in Japan: from Hokuriku atrial fibrillation trial.
    Furusho H; Takamura M; Takata S; Sakagami S; Hirazawa M; Kato T; Murai H; Okajima M; Kaneko S
    Circ J; 2008 Dec; 72(12):2058-61. PubMed ID: 18854614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboembolic prophylaxis in nonrheumatic atrial fibrillation: utilization patterns, efficacy, and complications in a long-term follow-up of community patients.
    Blich M; Gross B
    Int J Cardiol; 2004 Jul; 96(1):89-95. PubMed ID: 15203266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic prescribing in atrial fibrillation: application of a prescribing indicator and multidisciplinary feedback to improve prescribing.
    Elliott RA; Woodward MC; Oborne CA
    Age Ageing; 2002 Sep; 31(5):391-6. PubMed ID: 12242203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.
    Albers GW; Yim JM; Belew KM; Bittar N; Hattemer CR; Phillips BG; Kemp S; Hall EA; Morton DJ; Vlasses PH
    Arch Intern Med; 1996 Nov; 156(20):2311-6. PubMed ID: 8911237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic treatment in atrial fibrillation.
    Lip GY; Boos CJ
    Postgrad Med J; 2008 May; 84(991):252-8. PubMed ID: 18508982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.